We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
127 hedge funds and large institutions have $483M invested in Anika Therapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 49 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
2.2% more ownership
Funds ownership: 91.21% → 93.4% (+2.2%)
3% less funds holding
Funds holding: 131 → 127 (-4)
14% less capital invested
Capital invested by funds: $560M → $483M (-$76.5M)
14% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 49
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
Holders
127
Holders Change
-4
Holders Change %
-3.05%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
42
Reduced
49
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$6.63M |
| 2 |
Morgan Stanley
New York
|
+$5.04M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$4.33M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$2.27M |
| 5 |
BlackRock
New York
|
+$1.87M |
